First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment

Abstract

This study shows that although the baseline characteristics did not match, tenofovir and entecavir sustained comparable virological efficacies. More patients discontinued entecavir during follow-up. Both drugs provided effective viral control, with few side effects.